The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced
Continue reading »
FDA: N95 masks, now plentiful, should no longer be reused
Fox News Flash top headlines for April 23 Fox News Flash top headlines are here. Check out what’s clicking on
Continue reading »
CDC Director: All Schools Should Fully Open This Fall
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. All schools should be open for
Continue reading »
To Extract More Doses per Vial, Vaccinators Put Squeeze on FDA to Relax Vaccine Handling Advice
President Joe Biden has promised enough covid vaccine to immunize every willing adult by June 1. But right now, the
Continue reading »
FDA OKs Novel Dual-Action Stimulant Med for ADHD
The US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Continue reading »
FDA Clears Device to Protect Kids Against Head Injury
The US Food and Drug Administration (FDA) has cleared a new over-the-counter device designed to protect children aged 13 years
Continue reading »
Bladder Cancer Indication Withdrawn for Durvalumab
After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be
Continue reading »
Diverticulitis: A New Standard of Care?
Outpatient treatment of diverticulitis with amoxicillin-clavulanate is as effective as treatment with metronidazole plus a fluoroquinolone, according to a study
Continue reading »
FDA approves 1st long-acting HIV drug combo, monthly shots
Doctors may have cured second man of HIV Doctors in London performed a bone marrow transplant on the patient and
Continue reading »
Vertex Announces FDA Approvals of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor), Symdeko (tezacaftor/ivacaftor and ivacaftor) and Kalydeco (ivacaftor) for Use in People With CF With Certain Rare Mutations
BOSTON–(BUSINESS WIRE)–December 21, 2020 — Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) expanded
Continue reading »